Ann Arbor Stage IV Grade 3 Follicular Lymphoma Active Not Recruiting Phase 1 / 2 Trials for Rituximab (DB00073)

IndicationStatusPhase
DBCOND0093323 (Ann Arbor Stage IV Grade 3 Follicular Lymphoma)Active Not Recruiting1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01193842Vorinostat and Combination Chemotherapy With Rituximab in Treating Patients With HIV-Related Diffuse Large B-Cell Non-Hodgkin Lymphoma or Other Aggressive B-Cell LymphomasTreatment